[{"id":"0d7ff3cc-6422-42b2-8b6f-d9a6554297bf","acronym":"","url":"https://clinicaltrials.gov/study/NCT03123978","created_at":"2021-07-07T15:54:06.603Z","updated_at":"2024-07-02T16:35:49.518Z","phase":"Phase 1","brief_title":"Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer","source_id_and_acronym":"NCT03123978","lead_sponsor":"Mamta Parikh","biomarkers":" AR","pipe":" | ","alterations":" AR expression • AR splice variant 7 • AR-V7 expression • AR splice variant 7 expression","tags":["AR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AR expression • AR splice variant 7 • AR-V7 expression • AR splice variant 7 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Xtandi (enzalutamide) • niclosamide"],"overall_status":"Completed","enrollment":" Enrollment 6","initiation":"Initiation: 01/09/2017","start_date":" 01/09/2017","primary_txt":" Primary completion: 01/14/2022","primary_completion_date":" 01/14/2022","study_txt":" Completion: 04/19/2022","study_completion_date":" 04/19/2022","last_update_posted":"2023-04-26"}]